About Index Trending news
Analyze
Top 50 Pricing
ImaginAb

ImaginAb

Work at ImaginAb? Add yourself to this profile

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imagingby re-engineering antibodies into small proteins.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series Undisclosed)
$5,340,000
Venture capital (Series B)
$21,000,000
Cycad Group, Novartis Venture Fund, Nextech Invest, +1
Employees

Unknown size

Locations

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when ImaginAb makes some noise.